HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Industrial Cannabis/Industrial Hemp

668.188

-32.309-4.61%

Number of Gainers:1

Number of Losers:5

Number of Flat:1

PE:- -

High:698.203

Open:698.203

Low:660.145

Close:700.496

Volume:86.76M

Turnover:136.83M

Market Cap:26.55B

Float Cap:26.55B

Loading ...

Xuanzhu Biopharmaceutical to Join Hang Seng Index

MT Newswires Live

Xuanzhu Biopharmaceutical Joins Hang Seng Composite IndexXuanzhu Biopharmaceutical Co., Ltd. said it will be included as a constituent stock of the Hang Seng Composite Index following Hang Seng Indexes’ quarterly review, with the change taking effect on March 9, 2026

YNBY INTL Issues Profit Warning, Forecasts FY2025 Net Profit of HK$2.5-6.5 Million

YNBY International warns FY2025 profit may drop 65%-85% to HK$2.5 million-HK$6.5 million

YNBY International - Expected Result Due to Decrease of Gross Margin in FY

THOMSON REUTERS

YNBY International - Expects Net Profit Attributable of HK$2.5 Mln to HK$6.5 Mln for FY2025

THOMSON REUTERS

A Look At Sihuan Pharmaceutical Holdings Group (SEHK:460) Valuation After New Earnings Guidance And Segment Growth

Simply Wall St.

China Carbon Neutral Development Group to Approve Interim Results and Consider Dividend

BRIEF-Sihuan Pharma Sees Net Profit Of Not Less Than RMB150 Million For Year

Sihuan Pharmaceutical Issues Positive Profit Alert, Anticipates Revenue Exceeding RMB 25 Billion for Fiscal Year 2025

Sihuan Pharma Sees Net Profit of Not Less Than RMB150 Mln for Year

THOMSON REUTERS

Sihuan Pharma - Expects Revenue of at Least RMB2,500 Mln in FY

THOMSON REUTERS

Sihuan Pharmaceutical Expects Significant Profit Growth for 2025

Sealand Securities Starts Sihuan Pharmaceutical Holdings Group at Buy

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1600/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1600","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1600\",,,,,undefined,":{"symbol":"BK1600","market":"HK","secType":"PLATE","nameCN":"Industrial Cannabis/Industrial Hemp","latestPrice":668.1877,"timestamp":1771914345869,"preClose":700.4962,"halted":0,"volume":86755000,"delay":0,"changeRate":-0.046122,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-32.308533,"latestTime":"02-24 14:25:46","open":698.20264,"high":698.20264,"low":660.1454,"amount":136826610,"amplitude":0.054329,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771920600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1771896600000,1771905600000],[1771909200000,1771920000000]],"pbRate":2.323379,"peRate":370.564773,"turnoverRate":0.003101,"increases":0,"decrements":5,"flats":2,"marketCap":26553580120,"floatMarketCap":26553580120},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1600\",,,,,undefined,":{"symbol":"BK1600","high":698.20264,"amplitude":0.054329,"preClose":700.4962,"low":660.1454,"pbRate":"2.323379","latestPrice":668.1877,"volume":86755000,"delay":0,"open":698.20264,"prevYearClose":572.4504,"prevWeekClose":695.327,"prevMonthClose":676.894,"prevQuarterClose":572.45,"fiveDayClose":672.111,"twentyDayClose":612.895,"sixtyDayClose":630.164,"secType":"PLATE","market":"HK","turnoverRate":0.003101,"peRate":370.564773,"marketCap":26553580120,"floatMarketCap":26553580120,"timestamp":1771914345869,"nameCN":"Industrial Cannabis/Industrial Hemp"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1600\",,,,undefined,":{"bkCode":"BK1600","up":1,"down":5,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1600\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2613083972","title":"Xuanzhu Biopharmaceutical to Join Hang Seng Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2613083972","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613083972?lang=en_us&edition=fundamental","pubTime":"2026-02-23 10:01","pubTimestamp":1771812091,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group  said its non-wholly owned subsidiary Xuanzhu Biopharmaceutical  is due for inclusion to the Hang Seng Composite Index on March 9, according to a Hong Kong bourse filing Friday.Xuanzhu Biopharmaceutical went public in Hong Kong in October of last year.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1600","00460","BK1191","BK1515","02575","BK1593"],"gpt_icon":0},{"id":"2613222177","title":"**Xuanzhu Biopharmaceutical Joins Hang Seng Composite Index**Xuanzhu Biopharmaceutical Co., Ltd. said it will be included as a constituent stock of the Hang Seng Composite Index following Hang Seng Indexes’ quarterly review, with the change taking effect on March 9, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2613222177","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613222177?lang=en_us&edition=fundamental","pubTime":"2026-02-22 18:06","pubTimestamp":1771754767,"startTime":"0","endTime":"0","summary":"**Xuanzhu Biopharmaceutical Joins Hang Seng Composite Index** Xuanzhu Biopharmaceutical Co., Ltd. said it will be included as a constituent stock of the Hang Seng Composite Index following Hang Seng Indexes’ quarterly review, with the change taking effect on March 9, 2026. Xuanzhu Biopharmaceutical Co., Ltd. said it will be **added** as a constituent stock of the **Hang Seng Composite Index** following the Hang Seng Indexes Company’s quarterly review for the period ended Dec. 31, 2025, with the change effective March 9, 2026. The company said the inclusion reflects investor recognition of its value and growth potential and is expected to improve share liquidity and broaden its investor base.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260222:nNDL2nmBT7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","02575","BK1191","BK1600","BK1515","00460"],"gpt_icon":0},{"id":"1118373032","title":"YNBY INTL Issues Profit Warning, Forecasts FY2025 Net Profit of HK$2.5-6.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1118373032","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118373032?lang=en_us&edition=fundamental","pubTime":"2026-02-20 17:08","pubTimestamp":1771578493,"startTime":"0","endTime":"0","summary":"YNBY INTL (00030) announced that the group expects to report a net profit attributable to shareholders of HK$2.5 million to HK$6.5 million for the 2025 fiscal year. This compares to a net profit...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1121","00030"],"gpt_icon":0},{"id":"2612686032","title":"YNBY International warns FY2025 profit may drop 65%-85% to HK$2.5 million-HK$6.5 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2612686032","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612686032?lang=en_us&edition=fundamental","pubTime":"2026-02-20 17:01","pubTimestamp":1771578073,"startTime":"0","endTime":"0","summary":"YNBY International Ltd. expects net profit attributable to shareholders for FY2025 to fall to about HK$2.5 million–HK$6.5 million, down from roughly HK$18 million in FY2024, a decline of around 65%–85%. The company attributed the drop mainly to lower gross profit as gross margin is expected to compress to about 2%–5% from approximately 8.74%, driven by reduced sales of higher-margin products.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. YNBY International Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL6wgB8K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00030","BK0028","BK0164","000538","BK0188","BK0187","LU1960683339.HKD","LU1993786604.SGD","BK1600","LU1807302812.USD","BK1121","BK0175","BK0239","BK0196","BK0012"],"gpt_icon":0},{"id":"2612689802","title":"YNBY International - Expected Result Due to Decrease of Gross Margin in FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2612689802","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612689802?lang=en_us&edition=fundamental","pubTime":"2026-02-20 17:01","pubTimestamp":1771578072,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nFWN3ZF1IN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00030","BK1600","BK1121"],"gpt_icon":0},{"id":"2612268674","title":"YNBY International - Expects Net Profit Attributable of HK$2.5 Mln to HK$6.5 Mln for FY2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2612268674","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612268674?lang=en_us&edition=fundamental","pubTime":"2026-02-20 17:01","pubTimestamp":1771578072,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nFWN3ZF1IN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1600","00030","BK1121"],"gpt_icon":0},{"id":"2612405689","title":"A Look At Sihuan Pharmaceutical Holdings Group (SEHK:460) Valuation After New Earnings Guidance And Segment Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2612405689","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612405689?lang=en_us&edition=fundamental","pubTime":"2026-02-19 15:42","pubTimestamp":1771486935,"startTime":"0","endTime":"0","summary":"Guidance-driven spotlight on Sihuan Pharmaceutical Holdings Group\nSihuan Pharmaceutical Holdings Group (SEHK:460) caught investor attention after issuing unaudited 2025 earnings guidance, indicating at least RMB 2,500 million in revenue and RMB 150 million in net profit for the year.\nSee our latest analysis for Sihuan Pharmaceutical Holdings Group.\nThe earnings guidance lands after a strong run in the share price, with a 30 day share price return of 25.19% and a year to date gain of 28.12%...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/a-look-at-sihuan-pharmaceutical-holdings-group-sehk460-valua","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/a-look-at-sihuan-pharmaceutical-holdings-group-sehk460-valua","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK1593","00460","BK1600","BK1191","BK1515"],"gpt_icon":0},{"id":"2610945486","title":"China Carbon Neutral Development Group to Approve Interim Results and Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2610945486","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610945486?lang=en_us&edition=fundamental","pubTime":"2026-02-12 17:09","pubTimestamp":1770887388,"startTime":"0","endTime":"0","summary":"China Carbon Neutral Development Group Ltd. has announced that its Board of Directors will hold a meeting on 27 February 2026, Friday. The meeting will be convened to approve the interim results of the Group for the six months ended 31 December 2025 and to consider the payment of an interim dividend, if any. Further details are available in the official announcement by the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Carbon Neutral Development Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nNDL8PfSJx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01372","BK1144","BK1600","BK1148","BK1594"],"gpt_icon":0},{"id":"2610262130","title":"BRIEF-Sihuan Pharma Sees Net Profit Of Not Less Than RMB150 Million For Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2610262130","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610262130?lang=en_us&edition=fundamental","pubTime":"2026-02-10 23:17","pubTimestamp":1770736620,"startTime":"0","endTime":"0","summary":"BRIEF-Sihuan Pharma Sees Net Profit Of Not Less Than RMB150 Million For YearFeb 10  - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:SEES NET PROFIT OF NOT LESS THAN RMB150 MILLION FOR YEAREXPECTS REVENUE OF AT LEAST RMB2,500 MILLION IN FYFurther company coverage: 0460.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z60OR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1515","BK1593","BK1600","00460"],"gpt_icon":0},{"id":"1192554954","title":"Sihuan Pharmaceutical Issues Positive Profit Alert, Anticipates Revenue Exceeding RMB 25 Billion for Fiscal Year 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1192554954","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192554954?lang=en_us&edition=fundamental","pubTime":"2026-02-10 23:07","pubTimestamp":1770736068,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical (00460) has announced a positive profit alert. Based on a preliminary assessment of the company's unaudited consolidated management accounts and current information available to...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1515","BK1600","BK1593","00460"],"gpt_icon":0},{"id":"2610629912","title":"Sihuan Pharma Sees Net Profit of Not Less Than RMB150 Mln for Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2610629912","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610629912?lang=en_us&edition=fundamental","pubTime":"2026-02-10 22:54","pubTimestamp":1770735272,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z60OR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1593","BK1191","BK1600","BK1515","00460"],"gpt_icon":0},{"id":"2610629911","title":"Sihuan Pharma - Expects Revenue of at Least RMB2,500 Mln in FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2610629911","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610629911?lang=en_us&edition=fundamental","pubTime":"2026-02-10 22:54","pubTimestamp":1770735272,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z60OR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1600","BK1191","00460","BK1593"],"gpt_icon":0},{"id":"2610629949","title":"Sihuan Pharmaceutical Expects Significant Profit Growth for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2610629949","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610629949?lang=en_us&edition=fundamental","pubTime":"2026-02-10 22:54","pubTimestamp":1770735252,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. has issued a positive profit alert for the year, indicating a significant improvement in business performance. The company highlighted that its innovative drug business has entered a harvest period, with subsidiaries Xuanzhu Biopharm and Huisheng Biopharm achieving notable year-on-year revenue growth. Sihuan Pharmaceutical also reported a transition from an investment phase to a revenue-generating phase in its innovative drug segment, leading to a marked enhancement in its profit structure. Additionally, the company noted substantial equity appreciation gains following the successful spin-off listing of Xuanzhu Biopharm and multiple rounds of share repurchases, which have strengthened its financial position and driven breakthroughs in profitability.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDL137MZR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575","BK1515","BK1593","BK1600","00460","BK1191"],"gpt_icon":0},{"id":"2610343886","title":"Sealand Securities Starts Sihuan Pharmaceutical Holdings Group at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2610343886","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610343886?lang=en_us&edition=fundamental","pubTime":"2026-02-09 19:16","pubTimestamp":1770635761,"startTime":"0","endTime":"0","summary":"Sealand Securities Starts Sihuan Pharmaceutical Holdings Group at Buy","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","BK1515","BK1600","BK1593","00460"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}]}}